Blog - Page 3847 of 5712

TuesdayMay 25, 2010 7:17 am

General Environmental Management Inc. (GEVI.OB) Reports First Time Profitability with First Quarter 2010 Financial Results

Yesterday after the closing bell, General Environmental Management Inc. (GEM) announced its financial results for the three months ended March 31, 2010. The company reported first-quarter GAAP (generally accepted accounting principles) earnings per share (EPS) at $0.30. For the first time in Company history, GEM has recorded a quarterly net income. Total net income for the quarter was calculated at $4,477,955. In the press release, the company made it clear that revenues for the first quarter are strictly from the Southern California Waste Water (SCWW) subsidiary, due to the discontinuation of all other segments of the GEM hazardous waste business.…

TuesdayMay 25, 2010 7:03 am

Newport Digital Technology, Inc. (NPDT.OB) Announces Introduction of RFID Products Compliant with Secure RFID Protocol

Newport Digital Technologies, Inc. announced early this morning that they have introduced Secure RFID Protocol compliant reader-writer (RW), inlays, tags, and integrated circuit chips to its N37B RFID product offering. This secure protocol supports data protection and confidentiality of multiple data profiles for business-sensitive data and consumer privacy protection. Hitachi, Ltd., a global technology leader, will provide the Secure RFID Protocol related technology and support the company in developing the product. They will also handle business development and marketing support. The Secure RFID Protocol, developed by Hitachi based on the ISO 18000-6 type C Standard and EPC C1Gen2 Standard, provides…

MondayMay 24, 2010 3:26 pm

Vasomedical Inc. (VASO.OB) Up 80% Following Mention in QualityStocks Newsletter

Vasomedical Inc. closed today's trading at $0.21 a share, up $0.6 or 40% for the day. The upsurge in price has been accompanied by an upsurge in volume as well, with today's traded shares totaling 3.8 million, which is about 18 times the normal daily volume. The company was first covered in QualityStocks Free Daily Newsletter back on April 7, 2009. At the time, the stock was trading for only $0.04 a share. Investors that bought the stock at that time have enjoyed seeing their investment grow by 425%! Vasomedical designs, manufactures, markets and supports EECP(R) external counterpulsation systems based…

MondayMay 24, 2010 1:43 pm

National Automation Services, Inc. (NASV.PK) Increases Industrial and Technical Diversity

National Automation Services Inc., rapidly solidifying its position as a national leader in advanced automation and control systems solutions, is using its growing portfolio of experience and project success to expand its industrial presence. The company’s industrial list continues to grow, with most clients currently in the following industries: water/wastewater, substation automation, motion control, delivery systems, semiconductor, and pharmaceutical industries. The focus and depth of National’s PLC and SCADA programming experience is significant, including both stand-alone and networked SCADA systems. The company has many sites with remote access and dial-out options, such as Web Pages, Software Alarm Dialers, and PC…

MondayMay 24, 2010 12:45 pm

Consorteum Holdings, Inc. (CSRH.OB) Recently Announced Initiative for Streamlined Efficiency

Consorteum Holdings Inc. has extensive expertise within the payments and transaction industry globally. By identifying new technologies and trends in the marketplace, the company aims to increase revenues in existing markets, enter new markets, and deliver unique products and services more effectively and efficiently. The company recently announced its intent to divide the company into the operational divisions it has been creating over the last 12 months. Consorteum will be divided into three main business units: Consorteum Financial Services, MyGolf Rewards and Technology Services. Consorteum Financial Services will focus on new initiatives targeting the traditional payment markets, working with established…

MondayMay 24, 2010 12:41 pm

NanoViricides, Inc. (NNVC.OB) Files Quarterly Report with SEC

Nanoviricides Inc. is a development stage company creating special purpose nanomaterials for viral therapy. The company's novel nanoviricide class of drug candidates are designed to specifically attack enveloped virus particles and dismantle them. The company is developing drugs against a wide variety of viral diseases. The company filed its quarterly report with the Securities and Exchange Commission (SEC) on May 20, 2010. Nanoviricides reported that it had approximately $2.85 million in cash and $305,000 in prepaid expenses as of the end of the quarter – March 31, 2010. The company also reported it spent approximately $1.583 million in research and…

MondayMay 24, 2010 11:53 am

Image Metrics Inc. (IMGX.OB) Posts Solid Q2 Results, Gives Future Expectations

Image Metrics Inc., a provider of facial animation software and services for the entertainment and film industry, today posted its financial results for the second quarter ended March 31, 2010. Image Metrics posted second-quarter revenue for 2010 at $1.6 million compared to $0.2 million in the year-ago period. The company attributes the increase primarily to growth in its customer base, and the expanding pipeline of full-service facial animation work for clients largely in the video game industry. The company also executed efforts to expand its internal sales and marketing team over the past year. Revenue for the first half of…

MondayMay 24, 2010 11:51 am

Pro-Pharmaceuticals, Inc. (PRWP.OB) Announces Plans to Submit Phase III Trial Design to FDA

Pro-Pharmaceuticals Inc. engages in the discovery, development and commercialization of advanced treatment of cancer and fibrosis. The company today said it plans to submit a phase III trial design for DAVANAT to the U.S. Food and Drug Administration during the second half of this year. DAVANAT is Pro-Pharmaceutical’s lead product candidate for cancer patients. Data from the phase II trial for end-stage colorectal cancer patients demonstrated that DAVANAT used in combination with 5-FU extended median survival 46 percent longer than the best standard of care as determined by the patients’ physicians. "I believe that DAVANAT will be a game-changer in…

MondayMay 24, 2010 10:28 am

Grey Television Inc. (GTN) Announces Gains in First Quarter 2010 Advertising Revenues

Perhaps one of the largest swings attributed to the digital age can be found in television advertising. As people are offered more options for entertainment, advertising revenues have fallen. Of late, however, revenue streams have started to shift back toward innovative television companies that were wise enough to diversify their advertising base to accommodate this change. Although a risky investment to be sure, finding a media company that has worked to change their strategies toward revenue generation may quite possibly be a profitable one. Grey Television Inc., a company operating as a television broadcast concern, operates 36 television stations in…

MondayMay 24, 2010 10:19 am

Cellceutix Corp. (CTIX.OB) Moves Closer to Human Trials with Kevetrin™

Cellceutix Corp. announced today that they have reached agreements with PharPoint Reasearch and Medical Research Consulting Services for Phase 1 clinical trials of their lead compound, Kevetrin, which is being developed to target drug-resistant cancers. PharPoint will handle data management and statistical analysis while Medical Research will be responsible for clinical monitoring throughout the human trials. Art Holmes, President of PharPoint, was quoted in the press release as stating, “We are pleased to have the opportunity to work with Cellceutix and to bring our skills to bear on the Kevetrin Phase 1 study,” Mr. Holmes continued, “From a corporate standpoint,…

Site Search

Company Search